WHO confirms the quality of the Russian influenza vaccine "Flu-M", 02.27.2023.
The FMBA reported that WHO confirmed the quality of the Russian influenza vaccine "Flu-M".
MOSCOW, February 27 - RIA Novosti. The World Health Organization has confirmed the quality of the Russian influenza vaccine Flu-M, developed by specialists from the Federal Medical and Biological Agency, the press service of the Federal Medical and Biological Agency of Russia reported.
"As part of the prequalification procedure, two independent laboratories of the World Health Organization ( WHO ) confirmed the high quality of the Flu-M flu vaccine developed by the St. in the message.
The evaluation was carried out according to the WHO requirements for influenza vaccine. The test results confirmed the acceptability of the seasonal flu vaccine, the press service said.
"Own technology for the production of vaccines from a strain to a finished product makes it possible to achieve high-quality purification of antigens, in which the content of ovalbumin (the main allergen of a chicken egg) is in the range of 1-2 ng at a dose, which is a thousand times less than the permissible norms," said the head of the FMBA of Russia Veronika Skvortsova , whose words are given in the message.
https://ria.ru/20230227/vaktsina-1854720098.html
The FMBA reported that WHO confirmed the quality of the Russian influenza vaccine "Flu-M".
MOSCOW, February 27 - RIA Novosti. The World Health Organization has confirmed the quality of the Russian influenza vaccine Flu-M, developed by specialists from the Federal Medical and Biological Agency, the press service of the Federal Medical and Biological Agency of Russia reported.
"As part of the prequalification procedure, two independent laboratories of the World Health Organization ( WHO ) confirmed the high quality of the Flu-M flu vaccine developed by the St. in the message.
The evaluation was carried out according to the WHO requirements for influenza vaccine. The test results confirmed the acceptability of the seasonal flu vaccine, the press service said.
"Own technology for the production of vaccines from a strain to a finished product makes it possible to achieve high-quality purification of antigens, in which the content of ovalbumin (the main allergen of a chicken egg) is in the range of 1-2 ng at a dose, which is a thousand times less than the permissible norms," said the head of the FMBA of Russia Veronika Skvortsova , whose words are given in the message.
https://ria.ru/20230227/vaktsina-1854720098.html